Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Krauss (Giessen, Germany), B. Ait Ilalne (Paris, France), C. Knittel (Giessen, Germany), J. Wilhelm (Giessen, Germany), R. Dartsch (Giessen, Germany), S. Tello (Giessen, Germany), P. Mahavadi (Giessen, Germany), M. Korfei (Giessen, Germany), W. Seeger (Giessen, Germany), B. Crestani (Paris, France), A. Guenther (Giessen, Germany). Impact of tidal volume, GAP index and anti-fibrotic treatment on disease progression and mortality in IPF patients. 1850

Member's Comments

No comment yet.

Related content which might interest you: Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy Source: Eur Respir J 2006; 27: 689-696 Year: 2006 Modified GAP index by including serum KL-6 to assess risk of disease progression in patients with interstitial lung diseases (ILD): preliminary results from the VAMOS study. Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021 The effect of lung volume reduction on the success of physical activity coaching in patients with severe COPD Source: Virtual Congress 2020 – Physical activity and chronic lung disease: once a new kid, now growing up Year: 2020 Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 Weight loss as a predictor of mortality in patients with interstitial lung disease Source: Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018 Year: 2018 Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD) Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Lung function reversibility as a predictor of disease progression in COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017 The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002 Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2006 - COPD therapy Year: 2006 The loss of the beneficial effect of deep inspiration (DI) in COPD is associated with severity of disease Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016 Year: 2017 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016 Year: 2017 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 Active asthma and longer disease duration associated with more hyperinflation and increased diffusion capacity – TRAIL Cohort Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients Source: ERJ Open Res, 5 (2) 00021-2019; 10.1183/23120541.00021-2019 Year: 2019 Short term change in modified BODE (mBODE) in severe emphysema patients predicts mortality with lung volume reduction surgery (LVRS) Source: Eur Respir J 2006; 28: Suppl. 50, 569s Year: 2006 Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015